Clik here to view.
Octapharma Group公布2016年业绩，录得营收16亿欧元，运营收入3.83亿欧元
瑞士拉亨 (美国商业资讯)–Octapharma Group公布了创纪录的业绩，其销售额达到了16亿欧元，较2015年增长5.8%，或增长8,700万欧元。 Octapharma的北美销售额增长了18.8%，东欧增长了14%，西欧成熟市场增长了6%。业绩增长主要归功于Octapharma的免疫球蛋白产品octagam® 和gammanorm®...
View ArticleClik here to view.
Mauna Kea Technologies: Superiority of Endomicroscopy for the Diagnosis of...
PARIS Regulatory News: Mauna Kea Technologies (Paris:MKEA) (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced...
View ArticleClik here to view.
大塚製薬による米国バイオベンチャー「ニューロバンス社」の買収について
東京 （ビジネスワイヤ） – 大塚製薬株式会社（本社：東京都、代表取締役社長：樋口達夫、以下「大塚製薬」）はNeurovance, Inc.（本社：米国マサチューセッツ州ケンブリッジ、 Executive Chairman & CEO：ジェフ・ベイリー、以下「ニューロバンス社」）と、3月2日（米国東部時間）、大塚アメリカインク（大塚製薬の100%子会社：Otsuka America...
View ArticleClik here to view.
Otsuka Pharmaceutical to Acquire Neurovance, Inc.
TOKYO Otsuka Pharmaceutical Co., Ltd. (OPC) today announces an agreement with Neurovance, Inc. (Neurovance) under which OPC has agreed to acquire Neurovance, a privately held, venture-funded,...
View ArticleClik here to view.
The UK High Court of Justice (Patents) Rules in Fujifilm Kyowa Kirin...
TOKYO FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd. (President and CEO: Hideaki Nomura; “Fujifilm Kyowa Kirin Biologics”) today announced that on March 3, 2017, the UK High Court of Justice ruled in...
View ArticleClik here to view.
レブラミド（レナリドミド）が初発多発性骨髄腫患者の自家幹細胞移植後の維持療法を目的とした単剤療法として欧州委員会より承認される
スイス・ブードリー （ビジネスワイヤ） — セルジーン・コーポレーション（NASDAQ:...
View ArticleClik here to view.
Danimer Scientific与百事公司就生物降解树脂研发开展合作
佐治亚州班布里奇和纽约帕切斯 (美国商业资讯)–生物技术领军企业Danimer Scientifics与全球餐饮公司百事公司(PepsiCo，Inc., PEP)宣布达成协议，Danimer Scientifics将为百事公司研发可生物降解的成膜树脂材料，以满足百事公司全球食品和饮料业务的可持续性软包装要求。 Smart News...
View ArticleClik here to view.
New Study by Morinaga Milk, Using Cutting Edge Technology, Confirms...
TOKYO Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading dairy product company in Japan, today announced the results of a new study that show how gut microbiota composition in a healthy human...
View ArticleClik here to view.
Richard L. Wang Named Chief Executive Officer of Fosun Kite Biotechnology...
SANTA MONICA, Calif. Kite Pharma, Inc., (Nasdaq:KITE) today announced that Richard L. Wang, Ph.D. will be appointed Chief Executive Officer of Fosun Kite Biotechnology Co., Ltd, the company’s 50/50...
View ArticleClik here to view.
オクタファルマ・グループが2016年業績を発表、売上高は16億ユーロ、営業利益は3億8300万ユーロを記録
スイス・ラッヘン （ビジネスワイヤ） — オクタファルマ・グループが発表した2016年業績は過去最高となり、売上高は2015年に比べて8700万ユーロ、5.8%の増加となる16億ユーロに達しました。...
View ArticleClik here to view.
Avita Medical Announces Last Patient Visit in U.S. Pivotal Trial
VALENCIA, Calif. & PERTH, Australia & CAMBRIDGE, England Avita Medical Limited (ASX:AVH; OTCQX:AVMXY), a regenerative medicine company focused on the treatment of wounds and skin defects,...
View ArticleClik here to view.
Multiple Abstracts Concerning MIS416 Mechanism of Action Accepted for...
SYDNEY Innate Immunotherapeutics Limited (ASX Code: IIL), together with a number of Australian, Canadian, and Danish scientific collaborators, has had multiple abstracts accepted for presentation at...
View ArticleClik here to view.
ZS Genetics, Inc. and Hitachi High Technologies America, Inc. Enter Strategic...
WAKEFIELD, Mass. & CLARKSBURG, Md. ZS Genetics, Inc. and Hitachi High Technologies America, Inc. (HTA) announced today a strategic collaboration to develop and commercialize ZS Genetics’ DNA...
View ArticleClik here to view.
森永乳业的新研究采用最新技术证实了人类肠道微生物的年龄相关演变
东京 (美国商业资讯) — 日本领先的乳制品公司森永乳业株式会社(Morinaga Milk Industry Co., Ltd.,...
View ArticleClik here to view.
Sosei Subsidiary Heptares and Daiichi Sankyo to Discover and Develop Novel,...
TOKYO Sosei Group Corporation (“Sosei”; TSE Mothers Index:4565) reported that its subsidiaries, Heptares Therapeutics (“Heptares”) has announced that it have entered into a drug discovery and...
View ArticleClik here to view.
Protalex Significantly Strengthens Global Intellectual Property Portfolio for...
FLORHAM PARK, N.J. Protalex, Inc. (OTCQB:PRTX), a clinical-stage biopharmaceutical company, announces that the Company has been granted several key patents for PRTX-100, the Company’s highly...
View ArticleClik here to view.
Enanta Announces Japanese Ministry of Health, Labour and Welfare Grants...
WATERTOWN, Mass. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver...
View ArticleClik here to view.
AllAccem Announces Human Dental Product Presentation at the 2017...
SAN CARLOS, Calif. AllAccem, Inc., a pharmaceutical and medical device products developer and manufacturer, announced today that Karin M. Hold, PhD is presenting the poster titled “Biocompatibility...
View ArticleClik here to view.
SpinalCyte的里程碑式试验完成首例成纤维细胞注射以促使椎间盘再生
休斯敦 (美国商业资讯) — SpinalCyte, LLC是一家总部位于美国德州的组织工程技术公司，专注于采用人类皮肤成纤维细胞进行椎间盘髓核的再生。该公司今天宣布，已完成首例成纤维细胞注射以促使椎间盘再生。CybroCell是首个用于治疗退行性椎间盘疾病的皮肤成纤维细胞产品。该手术采用局部麻醉，在15分钟以内完成。患者未出现并发症，在1小时内出院。 SpinalCyte首席执行官Pete...
View ArticleClik here to view.
Medical Device Company Visioneering Technologies Successfully Raises $33.3...
ALPHARETTA, Ga. Visioneering Technologies, Inc. (VTI), a US-based medical device company engaged in the design, manufacture, sale and distribution of its proprietary NaturalVue™ Multifocal 1 Day...
View Article